
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Showing 21 citing articles:
Trends in tuberculosis mortality among older adults in China, 2004–2021: a Joinpoint regression and age–period–cohort analysis
Mengdi Zhang, Xin Wang, Yiran Xiao, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Mengdi Zhang, Xin Wang, Yiran Xiao, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
Andrea Picchianti Diamanti, Alessandra Aiello, Chiara De Lorenzo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Andrea Picchianti Diamanti, Alessandra Aiello, Chiara De Lorenzo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital
Virginia Di Bari, Carlotta Cerva, Raffaella Libertone, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 11-11
Open Access
Virginia Di Bari, Carlotta Cerva, Raffaella Libertone, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 11-11
Open Access
The interplay of tuberculosis and COVID-19: Insights into global health challenges
Kirtimaan Syal
Journal of Biosciences (2025) Vol. 50, Iss. 1
Closed Access
Kirtimaan Syal
Journal of Biosciences (2025) Vol. 50, Iss. 1
Closed Access
Mutations in ace2 gene modulate cytokine levels and alter immune responses in Mycobacterium tuberculosis and SARS-CoV-2 co-infection: a Cameroonian cohort
Mary Ngongang Kameni, Eric Berenger Tchoupe, Séverin Donald Kamdem, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Mary Ngongang Kameni, Eric Berenger Tchoupe, Séverin Donald Kamdem, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN ‐FRT expert consensus
Tiago Torres, Nicolò Costantino Brembilla, Richard Langley, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 4
Tiago Torres, Nicolò Costantino Brembilla, Richard Langley, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 4
Therapy modulates the response to T cell epitopes over the spectrum of tuberculosis infection
Linda Petrone, Daniela Peruzzu, Anna Maria Gerarda Altera, et al.
Journal of Infection (2024), pp. 106295-106295
Open Access | Times Cited: 4
Linda Petrone, Daniela Peruzzu, Anna Maria Gerarda Altera, et al.
Journal of Infection (2024), pp. 106295-106295
Open Access | Times Cited: 4
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
Tonino Alonzi, Alessandra Aiello, Michela Sali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117153-117153
Open Access | Times Cited: 3
Tonino Alonzi, Alessandra Aiello, Michela Sali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117153-117153
Open Access | Times Cited: 3
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
Brittany D. Williams, Debora Ferede, Hazem F. M. Abdelaal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Brittany D. Williams, Debora Ferede, Hazem F. M. Abdelaal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease
Anna Allué‐Guardia, Jordi B. Torrelles, Alex Sigal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Anna Allué‐Guardia, Jordi B. Torrelles, Alex Sigal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Sex disparities of the effect of the COVID-19 pandemic on mortality among patients living with tuberculosis in the United States
Huan Deng, Yishan Liu, Fan Lv, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Huan Deng, Yishan Liu, Fan Lv, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
T cells exhaustion, inflammatory and cellular activity markers in PBMCs predict treatment outcome in pulmonary tuberculosis patients
Jacob Nii Otinkorang Ankrah, Fredrick Gyilbagr, Ezekiel Kofi Vicar, et al.
Cytokine (2024) Vol. 182, pp. 156708-156708
Closed Access | Times Cited: 1
Jacob Nii Otinkorang Ankrah, Fredrick Gyilbagr, Ezekiel Kofi Vicar, et al.
Cytokine (2024) Vol. 182, pp. 156708-156708
Closed Access | Times Cited: 1
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Saeid Najafi Fard, Chiara Farroni, Linda Petrone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Saeid Najafi Fard, Chiara Farroni, Linda Petrone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Aspectos biológicos e clínicos da coinfecção tuberculose e COVID-19: uma revisão sistemática
Juliana Silva de Santana, Irapuan Oliveira Pinheiro, Ulísses Ramos Montarroyos
Contribuciones a las Ciencias Sociales (2024) Vol. 17, Iss. 1, pp. 8242-8255
Open Access
Juliana Silva de Santana, Irapuan Oliveira Pinheiro, Ulísses Ramos Montarroyos
Contribuciones a las Ciencias Sociales (2024) Vol. 17, Iss. 1, pp. 8242-8255
Open Access
Cell-Mediated Immune Response Against Mycobacterium tuberculosis and Its Potential Therapeutic Impact
Harshika Khanna, Sarika Gupta, Yasmeen Sheikh
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 6, pp. 244-259
Closed Access
Harshika Khanna, Sarika Gupta, Yasmeen Sheikh
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 6, pp. 244-259
Closed Access
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial
Pengfei Jin, Qiao Liu, Wen‐Li Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1041-1051
Open Access
Pengfei Jin, Qiao Liu, Wen‐Li Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1041-1051
Open Access
Human ace2 and tmprss2 polymorphisms for predicting susceptibility to tuberculosis and COVID-19 co-infection in Cameroonian cohort.
Mary Ngongang Kameni, Eric Berenger Tchoupe, Séverin Donald Kamdem, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mary Ngongang Kameni, Eric Berenger Tchoupe, Séverin Donald Kamdem, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Interaction between type 2 diabetes and past COVID-19 on active tuberculosis
Liz E. Calles-Cabanillas, Génesis P. Aguillón-Durán, Doris Ayala, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Liz E. Calles-Cabanillas, Génesis P. Aguillón-Durán, Doris Ayala, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
T Cell Response in Tuberculosis-Infected Patients Vaccinated against COVID-19
Luiz Henrique Agra Cavalcante‐Silva, Ericka Garcia Leite, Fernanda Silva Almeida, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2810-2810
Open Access | Times Cited: 1
Luiz Henrique Agra Cavalcante‐Silva, Ericka Garcia Leite, Fernanda Silva Almeida, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2810-2810
Open Access | Times Cited: 1
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy)
Francesca Mariotti, Francesco Sponchiado, Filippo Lagi, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 758-765
Open Access
Francesca Mariotti, Francesco Sponchiado, Filippo Lagi, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 758-765
Open Access